(Press-News.org) Pupils with special educational needs and disabilities (SEND) are continuing to fall behind their peers with the gap widening despite the introduction of SEND legislation.
This is according to a new study by Durham University which analysed data on 2.5 million Year 6 pupils across four school years from 2014-2019.
The research suggests there is a need to re-evaluate the policies for SEND provision and how pupils with SEND are supported in schools.
It calls for more investment to support SEND pupils and for increased professional development for teachers and teaching assistants.
Using data from the National Pupil Database for England, the researcher’s analysis focused on reading, mathematics and writing achievements, looking at variations by the type of special educational need and disability.
Across four cohorts of Year 6 pupils, students with SEND performed well below their typically developing peers in reading, writing, and maths skills, with the gap widening for most SEND categories.
This is despite ongoing efforts and the introduction of the Children and Families Act in 2014 and the SEND Code of Practice in 2015 which set out a legal framework for how children with SEND should be supported.
The study is published in the European Journal of Special Needs Education.
Study author, Dr Johny Daniel, from the School of Education at Durham University, said: “It is worrying to see that the attainment gap between pupils with SEND and their peers is widening. This shows that the current support mechanisms are not working.
“It is crucial that we invest more in the support for pupils with SEND and equip teaching staff through regular high-quality professional development. That way, we can have a more inclusive and equitable education system that meets the needs of all learners.”
Pupils with specific learning difficulties, like dyslexia, and those with speech, language, and communication needs are falling behind their peers by one-and-a-half to two years. For these pupils, the gap in maths is getting wider with each successive cohort, while the gap in writing, though still the biggest, has stayed about the same over time.
This trend means that a significant number of students are starting secondary school with gaps in the skills they need to fully engage with more complex topics.
Students with autism spectrum disorders are performing, on average, one year behind their typical peers in all three academic domains. Moreover, this achievement gap appears to be slightly widening with each successive cohort in the study.
Children with intellectual disabilities, including limited language, social and self-care skills, consistently show the largest achievement gap for reading, writing and maths, and the gap is increasing. For example, in maths, children with intellectual disabilities often face challenges that result in them being, on average, around three academic years behind their typical peers.
Previous studies have shown that teaching assistants who work with pupils with SEND do not always receive adequate training to implement the most effective support, with a lack of funding being one contributing factor.
Dr Daniel added: “We have a real opportunity to turn these trends around by investing in targeted support and ensuring that all teaching staff have the tools and training they need to meet the diverse needs of their students with additional needs.”
END
Pupils with SEND continue to fall behind their peers
2024-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits
2024-09-18
Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits
Just over half of heavier drinkers in England say they would make changes to their drinking if calorie labels for alcohol were introduced, according to a new study by UCL researchers.
The findings, the researchers said, suggested calorie labels could help some drinkers maintain a healthier weight.
The study, published in the journal BMJ Open, looked at survey responses from 4,683 adults in England to assess the impact that alcohol calorie labelling might have on people’s attitudes and drinking ...
Study first to link operating room design to shorter surgery
2024-09-18
LAWRENCE – Xiaobo Quan is proud that his study is the first of its kind to link operating room design to the length of knee- and hip-replacement surgeries.
Thus, the University of Kansas School of Architecture & Design associate professor believes its findings can be used to optimize spaces that will both produce better outcomes, via shorter surgeries, for patients and boost the hospital’s bottom line.
For the article “Can Operating Room Design Make Orthopedic Surgeries Shorter, Safer, and More Efficient?: A Quasi-Experimental Study,” ---------- link to: https://doi.org/10.1177/19375867241254529 --------- in the journal Health Environments Research & Design, ...
New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis
2024-09-18
A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.1
The findings, presented today at ECTRIMS 2024, suggest that concerns related to pregnancy may lead to delayed or reduced use of disease-modifying treatments (DMTs), even before pregnancy becomes a consideration.
In an extensive analysis of 22,657 patients with relapsing MS (74.2% women) who were on the French ...
Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer
2024-09-18
With publicly funded correlative science in the nation’s Cancer Cooperative Groups reduced to a trickle, Group leaders propose implementing a long-standing National Academy of Medicine recommendation to bring new money to this area of research through public-private partnerships. They also recommend major process changes to remove significant barriers for researchers to access the biological samples contributed by patients. The current Journal of Clinical Oncology issue features ‘Correlative Science in the Cooperative Group System—Re-Engineering for Success.’
This Position Paper represents consensus among Evanthia Galanis, MD, DSc for the Alliance for Clinical ...
Nawaz named ASME Fellow
2024-09-18
Kashif Nawaz, distinguished researcher and section head for Building Technologies Research at the Department of Energy’s Oak Ridge National Laboratory, has been named a Fellow of the American Society of Mechanical Engineers, or ASME. The Fellow grade recognizes outstanding engineering achievements for members with 10 or more years of active practice.
Nawaz joined ORNL in 2016 as a research scientist in buildings equipment. He specializes in the heating, cooling and dehumidification systems of buildings including the development of novel heat exchangers and enhanced phase-change material ...
U2opia signs license to commercialize anomaly-detection technology for cybersecurity
2024-09-18
U2opia Technology has licensed Situ and Heartbeat, a package of technologies from the Department of Energy’s Oak Ridge National Laboratory that offers a new method for advanced cybersecurity monitoring in real time. Situ, which discovers and understands otherwise-undetectable events by analyzing security data, will go to the market through a commercial license. The company will continue to explore opportunities for Heartbeat, which detects cyber attacks by focusing on the physical behavior of a protected device, through a research and development license.
U2opia Technology, a woman- and minority- led company, is directed by Maurice Singleton III, chief executive officer, ...
Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event
2024-09-18
Some of the most dramatic climatic events in our planet’s history are “Snowball Earth” events that happened hundreds of millions of years ago, when almost the entire planet was encased in ice up to 0.6 miles (1 kilometer) thick.
These “Snowball Earth” events have happened only a handful of times and do not occur on regular cycles. Each lasts for millions of years or tens of millions of years and is followed by dramatic warming, but the details of these transitions are poorly ...
Cleveland Clinic study is first to show success in treating rare blood disorder
2024-09-18
Wednesday, September 18, 2024, CLEVELAND: A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in 5,000 people worldwide. The trial, led by Keith McCrae, M.D., of Cleveland Clinic and supported by the National Institutes of Health, was stopped early because of these successful findings, and has been published in the New England Journal of Medicine.
The impetus for this trial was a single patient. About ...
Bone marrow cancer drug shows success in treatment of rare blood disorder
2024-09-18
A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide. The trial results, which are published in the New England Journal of Medicine, detail how patients with HHT given the drug, called pomalidomide, experienced a significant reduction in the severity of nosebleeds, needed fewer of the blood transfusions and iron infusions that HHT often demands, ...
Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder
2024-09-18
A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary hemorrhagic telangiectasia (HHT), the world's second-most-common inherited bleeding disorder, affects approximately 1-in-5,000 people and can have life-threatening complications, but there are currently no U.S. FDA-approved drugs to treat HHT. The PATH-HHT study, the first-ever randomized, placebo-controlled ...